MindBio Therapeutics Balance Sheet Health

Financial Health criteria checks 2/6

MindBio Therapeutics has a total shareholder equity of A$-5.7M and total debt of A$5.0M, which brings its debt-to-equity ratio to -87.4%. Its total assets and total liabilities are A$194.2K and A$5.9M respectively.

Key information

-87.4%

Debt to equity ratio

AU$5.02m

Debt

Interest coverage ration/a
CashAU$138.70k
Equity-AU$5.74m
Total liabilitiesAU$5.94m
Total assetsAU$194.17k

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: WF6 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: WF6 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: WF6 has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: WF6's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: WF6 has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: WF6 is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies